Labiana Health H1 2026 attributable net profit falls 49% to EUR 940,000
Bitget2026/10/27 15:24- Labiana Health's H1 2026 attributable net profit fell 49% to EUR 940,000, hurt by non-recurring financial expenses from cancelling Miralta/Blantyre financing.
- Turnover rose 5% to EUR 41.3 million, while Animal Health turnover climbed 10% to EUR 20.77 million.
- The Animal Health division secured 10 new international licensing agreements covering 28 products.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
AI Cloud Sector Faces a Key Moment: CoreWeave (CRWV.US) Set to Announce Earnings, Wells Fargo Remains Bullish
CoreWeave (CRWV.US) will release its third-quarter financial report after the U.S. stock market closes on Tuesday. This is seen as a key test for the strength of the new AI cloud sector.
JPMorgan raises target prices for Target and Walmart
Orient Precision Industries Holds Extraordinary Shareholders Meeting
Citi optimistic about international oil companies: low-cost resource reserves being rebuilt may drive energy sector to reverse a decade-long valuation discount
With oil prices in the mid-$70s range, Citi believes that global international oil companies (IOCs) can deliver a free cash flow yield of 7% to 8%, and achieve a real growth rate of 4% to 5% over a period of time.
Crypto prices
More
